Encyclopedia of Sleep and Circadian Rhythms

1. Cover image - p. Cover 2. Title page - p. ii 3. Table of Contents - p. iii 4. Front Matter of Volume 1 - p. iii 5. Front Matter of Volume 2 - p. iii 6. Front Matter of Volume 3 - p. iii 7. Front Matter of Volume 4 - p. iii 8. Front Matter of Volume 5 - p. iii 9. Front Matter of Volume 6 - p. iii 10. Copyright - p. iii 11. Editor-in-Chief - p. iii 12. Editorial Board - p. iii 13. Preface - p. iii 14. Permission Acknowledgments - p. iii 15. Volume 1 - p. iii 16. Basic Sleep/Circadian Concepts, Science, Deprivation/Alteration, and Mechanisms - p. iii 17. Background - p. iii 18. List of Illustrations - p. iii 19. List of Tables - p. iii 20. Perspectives - p. iii 21. A history of the scientific study of sleep - p. iii 22. History of sleep. REM sleep and the beginning of sleep medicine: a tribute to Dr. William C. Dement - p. iii 23. Normal human sleep - p. iii 24. Ontogeny of sleep - p. iii 25. Evolution of sleep (sleep phylogeny) - p. iii 26. Sleep in amphibians and reptiles - p. iii 27. Sleep and the circadian clock in insects - p. iii 28. Sleep in birds - p. iii 29. Sleep in aquatic species - p. iii 30. Mammalian sleep - p. iii 31. Healthy Sleep - p. iii 32. Healthy sleep: basic sleep tips - p. iii 33. Creating an optimal sleep and circadian rhythm environment - p. iii 34. Optimal sleep and circadian habits in infants and children - p. iii 35. Early childhood pediatric sleep concerns for parents: Cosleeping - p. iii 36. Optimal Sleep Habits in Adolescents - p. iii 37. Optimal sleep habits in middle-aged adults - p. iii 38. Optimal sleep and circadian rhythm habits in older adults - p. iii 39. Healthy aging and sleep - p. iii 40. Sex differences in sleep - p. iii 41. Nutrition and sleep - p. iii 42. Exercise and sleep - p. iii 43. When an individual should see a medical provider about sleep - p. iii 44. Dreaming - p. iii 45. History of the study of dreaming - p. iii 46. Dream interpretation - p. iii 47. The psychology of dreams - p. iii 48. Dreams, psychopathology, psychotherapy - p. iii 49. Dreaming and psychiatric disorders - p. iii 50. Neurobiology of dreams - p. iii 51. Sleep Deprivation/Fragmentation Paradigms - p. iii 52. Acute sleep deprivation in humans - p. iii 53. Partial and sleep-stage-selective deprivation - p. iii 54. Sleep fragmentation - p. iii 55. Nonrestorative Sleep - p. iii 56. Extrinsic Factors Affecting Sleep Loss/Deprivation - p. iii 57. Effects of light and temperature on sleep in adults and elderly - p. iii 58. Effects of noise on sleep - p. iii 59. Sleep and mental performance: effects of time-zone transitions - p. iii 60. Shift work - p. iii 61. Medications, drugs of abuse, and alcohol - p. iii 62. Age effects on cognitive impairment from sleep loss: contributing factors and individual differences - p. iii 63. Homeostatic and circadian influences - p. iii 64. Attention and memory changes - p. iii 65. Electroencephalographic and neurophysiological changes - p. iii 66. Metabolic and endocrine changes during sleep - p. iii 67. Thermoregulatory changes in conditions of sleep loss - p. iii 68. Biochemical correlates of prolonged wakefulness - p. iii 69. Immunologic changes - p. iii 70. Changes in gene expression - p. iii 71. Genetic effects - p. iii 72. Changes in affect - p. iii 73. Personality and psychopathic changes - p. iii 74. Sleep and body clock problems in patients with obsessive–compulsive disorder - p. iii 75. Sleep Loss in Disease States - p. iii 76. Sleep loss from major sleep disorders - p. iii 77. Sleep loss associated with medical conditions and diseases - p. iii 78. Special Populations Affected by Sleep Loss/Deprivation - p. iii 79. Adolescence - p. iii 80. Sleep in women during pregnancy and postpartum - p. iii 81. Consequences of Sleep Loss - p. iii 82. Sleep loss: impact on self-reported sleepiness, effort, performance, and motivation - p. iii 83. Impact of sleep loss on subjective and objective effort - p. iii 84. Social and economic impact (65) - p. iii 85. Occupational impact - p. iii 86. Military operational effectiveness - p. iii 87. Athletic performance; effects of sleep loss - p. iii 88. Medical resident/physician performance - p. iii 89. Driving risks and accidents - p. iii 90. Legal implications of sleep loss - p. iii 91. Short-Term Countermeasures for Sleep Loss Effects - p. iii 92. Short-term countermeasures for sleep loss effects - p. iii 93. Naps - p. iii 94. Critical Theoretical and Practical Issues - p. iii 95. The functions of sleep - p. iii 96. Phylogeny and the function of sleep - p. iii 97. Recovery from sleep loss - p. iii 98. Eliminating cumulative sleep debt and sleep satiation - p. iii 99. The role of pharmacological interventions for sleep deprivation and restriction - p. iii 100. Sleep length: findings and recommendations for future research - p. iii 101. Future of sleep research - p. iii 102. Lucid dreaming - p. iii 103. Volume 2 - p. iii 104. Anatomy, Physiology, and Pharmacology of Sleep and Circadian Rhythms - p. iii 105. Background - p. iii 106. Overview of physiological processes during sleep - p. iii 107. Chemical neuroanatomy of sleep–wake systems - p. iii 108. Neurotransmitters and neuropharmacology of sleep/wake regulations - p. iii 109. Chronobiology of Sleep - p. iii 110. Molecular mechanisms of the mammalian circadian system - p. iii 111. Sleep homeostasis - p. iii 112. Circadian rhythms and physiological processes - p. iii 113. Chronobiology of Sleep – Circadian Rhythms, Behavior, and Performance - p. iii 114. The influence of light, exercise, and behavior upon circadian rhythms - p. iii 115. Dim light melatonin onset (DLMO): clinical and methodological aspects - p. iii 116. Effects of melatonin and melatonin agonists on circadian rhythms - p. iii 117. Sleep and the Nervous System - p. iii 118. Basic sleep–wake mechanisms - p. iii 119. NREM sleep: anatomy and physiology - p. iii 120. REM sleep - p. iii 121. NREM-REM sleep regulation - p. iii 122. Electrophysiology of sleep–wake systems - p. iii 123. Neurochemistry of sleep - p. iii 124. Thermoregulatory changes in conditions of sleep loss - p. iii 125. Peripheral Nervous System and Sleep - p. iii 126. Optogenetics in the study of the central nervous system during sleep - p. iii 127. The facilitation of learning and memory by sleep - p. iii 128. Sleep and the Respiratory System - p. iii 129. The upper airway anatomy - p. iii 130. Respiratory physiology - p. iii 131. Sleep and the control of breathing - p. iii 132. Physiology and dynamics of the pharyngeal airway - p. iii 133. Effects of altitude on breathing during sleep - p. iii 134. The upper airway anatomy - p. iii 135. Sleep and Other Systems - p. iii 136. Sleep in cardiovascular disease - p. iii 137. Sleep and the peripheral vascular system - p. iii 138. Endocrinology of sleep - p. iii 139. Gastrointestinal physiology during sleep - p. iii 140. Pharmacology of Sleep - p. iii 141. Basic pharmacologic mechanisms of sleep - p. iii 142. Endogenous Sleep-Promoting Substances - p. iii 143. Concepts and pharmacotherapeutic principles of insomnia - p. iii 144. Benzodiazepine receptor agonists and sleep - p. iii 145. Effects of alcohol, caffeine, and cannabidiol on sleep - p. iii 146. Antidepressants and sleep - p. iii 147. Wake-promoting substances - p. iii 148. Wake-promoting medications - p. iii 149. Medications that disrupt sleep - p. iii 150. Sleep and the Nervous System - p. iii 151. Local circuits: the fundamental minimal unit for emergent sleep - p. iii 152. Tryptophan and melatonin as treatments - p. iii 153. Pharmacology of Sleep - p. iii 154. Sleep and the glymphatic system - p. iii 155. Assessment, Methodology, Training and Policies of Sleep and Circadian Rhythms - p. iii 156. Assessment - p. iii 157. History and physical exam - p. iii 158. Questionnaires and rating scales - p. iii 159. Rating scales to assess sleep disorders - p. iii 160. Chronobiological assessment - p. iii 161. Psychologic and psychiatric assessment - p. iii 162. Neurologic assessment - p. iii 163. Cardiac and cardiovascular assessment - p. iii 164. Respiratory assessment - p. iii 165. Gastrointestinal assessment - p. iii 166. Management of sleep disordered breathing in the hospitalized patient - p. iii 167. Instrumentation and Methodology - p. iii 168. Adult polysomnography - p. iii 169. Pediatric polysomnography (PSG) - p. iii 170. Portable monitoring - p. iii 171. Electroencephalography - p. iii 172. Monitoring and staging human sleep - p. iii 173. Respiratory monitoring during sleep - p. iii 174. Nocturnal penile tumescence (sleep related erection) - p. iii 175. Overview of objective tests to assess excessive sleepiness - p. iii 176. Actigraphy - p. iii 177. Actigraphy in children - p. iii 178. Multiple sleep latency test (MSLT) - p. iii 179. Maintenance of wakefulness test - p. iii 180. Psychomotor vigilance performance - p. iii 181. Neurocognitive testing - p. iii 182. Neuroimaging of sleep - p. iii 183. Training and Research - p. iii 184. Sleep technologist requirements - p. iii 185. Fellowship training for sleep medicine - p. iii 186. Board certification for sleep clinicians - p. iii 187. Funding sources for sleep-related research grants - p. iii 188. Designing and implementing sleep-related clinical trials - p. iii 189. Setting up a laboratory for sleep-related animal research - p. iii 190. Planning sleep-related animal and translational research - p. iii 191. Succeeding in an academic sleep environment - p. iii 192. Quality improvement in sleep medicine - p. iii 193. International sleep medicine and research training - NEW - p. iii 194. Policies and Procedures - p. iii 195. Accreditation for sleep centers - p. iii 196. Current challenges and opportunities in global sleep medicine - p. iii 197. Public policy, sleep science, and sleep medicine - p. iii 198. Sleep-related resources for patients and providers - p. iii 199. Volume 3 - p. iii 200. Insomnia - p. iii 201. Features, Factors, and Characteristics of Insomnia - p. iii 202. Ontogeny of insomnia - p. iii 203. Etiology and pathogenesis of insomnia - p. iii 204. Insomnia risk factors - p. iii 205. Familial and genetic factors - p. iii 206. Descriptions of Insomnia - p. iii 207. Insomnia: clinical presentation, diagnostic characterization, and etiological considerations - p. iii 208. Types of insomnia - p. iii 209. Chronic insomnia - p. iii 210. Acute insomnia - p. iii 211. Insomnia with objective short sleep duration - p. iii 212. Comorbid insomnia and mental illness - p. iii 213. Insomnia in young children - p. iii 214. Insomnia due to drug or substance abuse and dependence - p. iii 215. Assessing and treating insomnia with specific comorbidities - p. iii 216. Associations and Consequences of Insomnia - p. iii 217. Immune, neuroendocrine, and metabolic functions in insomnia disorder - p. iii 218. Mood and behavior - p. iii 219. Fatigue and sleepiness - p. iii 220. Diagnosis of Insomnia - p. iii 221. Insomnia: history and physical exam - p. iii 222. Diagnostic tools for insomnia - p. iii 223. Diagnostic algorithm for insomnia - p. iii 224. Behavioral treatment of insomnia - p. iii 225. Cognitive therapy for insomnia - p. iii 226. Pharmacologic treatment of insomnia - p. iii 227. Adjunctive and alternative treatment of insomnia - p. iii 228. Special considerations for the nonpharmacological treatment of insomnia - p. iii 229. Special Conditions, Disorders, and Clinical Issues for Insomnia - p. iii 230. Sex and gender differences - p. iii 231. Insomnia in children - p. iii 232. Insomnia in older adults - p. iii 233. Therapeutic and adverse drug effects - p. iii 234. Impact of neurological disorders on insomnia - p. iii 235. Impact of psychological disorders - p. iii 236. Legal implications of insomnia - p. iii 237. Future directions in insomnia diagnosis and treatment - p. iii 238. Health disparities and insomnia:Insomnia and physical health: the role of health disparities in defining risk - p. iii 239. Digital medicine for insomnia - p. iii 240. Hypersomnias - p. iii 241. Features, Factors, and Characteristics of Hypersomnias - p. iii 242. The history of narcolepsy - p. iii 243. Epidemiology of central disorders of hypersomnolence - p. iii 244. Ontogeny of hypersomnias - p. iii 245. Hypersomnolence – etiologies - p. iii 246. Pathogenesis of hypersomnolence - p. iii 247. Risk factors for hypersomnias - p. iii 248. Familial and genetic factors of narcolepsy - p. iii 249. Descriptions of Hypersomnias - p. iii 250. Overview of hypersomnolence - p. iii 251. Description of hypersomnias - p. iii 252. Associations and consequences of hypersomnolence - p. iii 253. The international classification of sleep disorders, third edition's classification of central disorders of hypersomnolence - p. iii 254. Narcolepsy with cataplexy - p. iii 255. Narcolepsy without cataplexy - p. iii 256. Narcolepsy due to a medical condition - p. iii 257. Recurrent hypersomnia; Kleine–Levin syndrome - p. iii 258. Idiopathic hypersomnia - p. iii 259. Induced insufficient sleep syndrome - p. iii 260. Hypersomnia due to a medication or substance - p. iii 261. Associations and Consequences of Hypersomnias - p. iii 262. Morbidity and mortality - p. iii 263. Effect on the central nervous system - p. iii 264. Mood and behavior - p. iii 265. Sleepiness - p. iii 266. Health-related quality of life in patients with hypersomnia - p. iii 267. The economic impact of sleep deprivation - p. iii 268. Individual and societal impact of hypersomnolence - p. iii 269. Diagnosis of Hypersomnias - p. iii 270. Hypersomnolence in children: screening and case finding - p. iii 271. Diagnostic tools for hypersomnias - p. iii 272. Diagnostic algorithm for hypersomnolence - p. iii 273. Treatment of hypersomnia - p. iii 274. Special considerations for treatment of hypersomnias - p. iii 275. Special Conditions, Disorders, and Clinical Issues for Hypersomnias - p. iii 276. Hypersomnias in children - p. iii 277. Hypersomnia in the elderly - p. iii 278. Medications and sleep - p. iii 279. Impact of other sleep disorders - p. iii 280. Impact of neurological diseases - p. iii 281. Impact of medical disorders - p. iii 282. Impact of psychiatric disorders - p. iii 283. Legal implications of hypersomnolence - p. iii 284. Future directions in hypersomnias: diagnosis and treatment - p. iii 285. Circadian Rhythm Sleep Disorders - p. iii 286. Features, Factors, and Characteristics of CRSD - p. iii 287. A brief history of circadian rhythm sleep disorders - p. iii 288. Circadian rhythm sleep disorder: genetic and environmental factors - p. iii 289. Descriptions of CRSD - p. iii 290. Overview and description of circadian rhythm sleep disorders - p. iii 291. Pathophysiology, associations, and consequences of circadian rhythm sleep wake disorders - p. iii 292. Delayed sleep-phase type - p. iii 293. Advanced sleep phase type - p. iii 294. Irregular sleep–wake rhythm disorder - p. iii 295. Non-24-h sleep–wake disorder (free-running type, nonentrained type, hypernychthemeral syndrome) in sighted and blind patients - p. iii 296. Jet lag type - p. iii 297. Shift work disorder and treatment - p. iii 298. Associations and Consequences of CRSD - p. iii 299. Cardiometabolic consequences of circadian disruption - p. iii 300. Sleepiness and fatigue in circadian rhythm sleep disorders - p. iii 301. Individual and societal impact - p. iii 302. Diagnosis of CRSD - p. iii 303. Diagnosis of circadian rhythm sleep wake disorders: history and physical examination - p. iii 304. Diagnostic algorithm for circadian rhythm sleep disorders (CRSD) - p. iii 305. Light and melatonin treatment for jet lag - p. iii 306. Light and melatonin treatment for shift work - p. iii 307. Adjunctive and alternative treatments of circadian rhythm sleep disorders - p. iii 308. Special Conditions, Disorders, and Clinical Issues for CRSD - p. iii 309. Circadian rhythm disorders: does sex matter? - p. iii 310. Circadian rhythm sleep-wake disorders in adolescents - p. iii 311. Age-related changes in circadian rhythms and non-visual responses to light during adulthood - p. iii 312. Medication effects - p. iii 313. Neurological and medical disorders: circadian rhythm disruption comorbidity - p. iii 314. The circadian component of mood disorders: the sleep-wake cycle, biological rhythms, and chronotherapeutics - p. iii 315. Special considerations and future directions in circadian rhythm sleep disorders diagnosis - p. iii 316. Disruption of circadian rhythms and sleep: role in carcinogenesis - p. iii 317. Legal implications of circadian rhythm sleep-wake disorders - p. iii 318. Volume 4 - p. iii 319. Sleep Related Breathing Disorders - p. iii 320. Features, Factors, and Characteristics of SRBD - p. iii 321. The history of the diagnosis and treatment of sleep-disordered breathing - p. iii 322. Epidemiology of sleep related breathing disorders - p. iii 323. Ontogeny of obstructive sleep apnea - p. iii 324. Phylogeny and animal models - p. iii 325. Pathophysiology of obstructive sleep apnea - p. iii 326. Arousals - p. iii 327. Risk factors for obstructive sleep apnea - p. iii 328. Genetics of obstructive sleep apnea - p. iii 329. Associations and consequences of OSA - p. iii 330. Descriptions of SRBD - p. iii 331. Primary central sleep apnea - p. iii 332. Central sleep apnea due to cheyne–stokes breathing pattern - p. iii 333. Central sleep apnea due to other medical disorders- not Cheyne-Stokes - p. iii 334. Central sleep apnea due to drug or substance - p. iii 335. Snoring - p. iii 336. Upper airway resistance syndrome - p. iii 337. Sleep disordered breathing in infancy - p. iii 338. Adult obstructive sleep apnea - p. iii 339. Obstructive sleep apnea in children - p. iii 340. Treatment-emergent central sleep apnea - p. iii 341. Sleep related idiopathic non-obstructive alveolar hypoventilation - p. iii 342. Congenital central alveolar hypoventilation syndrome - p. iii 343. Sleep and obstructive lung disease - p. iii 344. Sleep-related hypoventilation and hypoxemia due to neuromuscular and chest wall disorders - p. iii 345. Rapid-onset obesity with hypothalamic dysfunction, hypoventilation, and autonomic dysregulation (ROHHAD) - p. iii 346. Associations and Consequences of SRBD - p. iii 347. Morbidity and mortality of obstructive sleep apnea - p. iii 348. Executive and frontal lobe function - p. iii 349. Congestive heart failure and breathing - p. iii 350. Coronary heart disease in obstructive sleep apnea - p. iii 351. Hypertension - p. iii 352. Sleep apnea and stroke - p. iii 353. Impaired metabolism in obstructive sleep apnea - p. iii 354. Sleep and obesity - p. iii 355. Mood and behavior - p. iii 356. Sleepiness in sleep related breathing disorders - p. iii 357. Health-related quality of life in obstructive sleep apnea - p. iii 358. Individual and socioeconomic impact of sleep related breathing disorders - p. iii 359. Commercial transportation - p. iii 360. Diagnosis of SRBD - p. iii 361. History and physical examination—sleep-related breathing disorders - p. iii 362. Screening and case finding for obstructive sleep apnea - p. iii 363. Diagnostic algorithm for sleep-related breathing disorders - p. iii 364. Polysomnography - p. iii 365. Home Sleep Apnea Testing - p. iii 366. Upper airway imaging and endoscopy - p. iii 367. Continuous positive airway pressure - p. iii 368. Noninvasive bilevel positive airway pressure therapy - p. iii 369. Autotitrating positive airway pressure - p. iii 370. Adaptive servoventilation in treatment of sleep-disordered breathing - p. iii 371. Upper airway surgery in the adult - p. iii 372. Mandibular advancement splints for the treatment of obstructive sleep apnea - p. iii 373. Myofunctional therapy in obstructive sleep apnea - p. iii 374. Adjunctive and alternative therapies for obstructive sleep apnea - p. iii 375. Special Conditions, Disorders, and Clinical Issues of SRBD - p. iii 376. Sex-specific differences in patients with obstructive sleep apnea-hypopnea syndrome - p. iii 377. Pediatric obstructive sleep-disordered breathing - p. iii 378. Medication effects on sleep related breathing disorders - p. iii 379. Impact of other respiratory conditions and disorders during sleep - p. iii 380. Impact of psychiatric disorders - p. iii 381. Legal aspects of sleep-related breathing disorders - p. iii 382. Features, Factors, and Characteristics of SRMD - p. iii 383. The evolution of diagnostic rules and Standards for Sleep-Related Movement Disorders (SRMD) - p. iii 384. Epidemiology of sleep related movement disorders (SRMD) - p. iii 385. Etiologies of sleep-related movement disorders (SRMD) - p. iii 386. The genetics of restless legs syndrome - p. iii 387. Descriptions of SRMD - p. iii 388. Description of sleep-related movement disorders - p. iii 389. Sleep-related movement disorders - p. iii 390. Periodic limb movement disorder - p. iii 391. Sleep-related leg cramps - p. iii 392. Sleep bruxism - p. iii 393. Sleep-related rhythmic movement disorder - p. iii 394. Hypnagogic foot tremor (HFT) - p. iii 395. Associations and Consequences of SRMD - p. iii 396. The epidemiology of cardiovascular disease in the restless legs syndrome and periodic limb movements during sleep - p. iii 397. Mood, behavior, and sleepiness of sleep-related movement disorders - p. iii 398. Diagnosis of SRMD - p. iii 399. Sleep-related movement disorders: health-related quality of life - p. iii 400. Socioeconomic impact, comorbid conditions and consequences of sleep-related movement disorders - p. iii 401. Sleep-related movement disorder: history and physical examination - p. iii 402. Diagnostic algorithm for sleep related movement disorders (SRMDs) - p. iii 403. Treatment of sleep-related movement disorders - p. iii 404. Special considerations for treatment of sleep-related movement disorders - p. iii 405. Special Conditions, Disorders, and Clinical Issues of SRMD - p. iii 406. Gender differences in sleep-related movement disorders - p. iii 407. Approach to sleep-related movement disorders in children - p. iii 408. Age-related changes in PLMS characteristics of RLS patients - p. iii 409. Medication effects and sleep-related movement disorders - p. iii 410. Restless legs syndrome in internal medicine - p. iii 411. Volume 5 - p. iii 412. Parasomnias - p. iii 413. Features, Factors, and Characteristics of Parasomnias - p. iii 414. History—features, factors, and characteristics of parasomnias - p. iii 415. Descriptions of Parasomnias - p. iii 416. Epidemiology and risk factors for parasomnias in children and adults - p. iii 417. Ontogeny of parasomnias - p. iii 418. Pathogenesis of parasomnias - p. iii 419. Familial and genetic factors - p. iii 420. Parasomnias in children - p. iii 421. Pathophysiology, associations and consequences of parasomnias - p. iii 422. Classification of parasomnias and diagnostic criteria - p. iii 423. Confusional arousals - p. iii 424. Sleepwalking - p. iii 425. Sleep terrors - p. iii 426. REM sleep behavior disorder - p. iii 427. Recurrent isolated sleep paralysis - p. iii 428. Nightmare disorder - p. iii 429. Sleep-related dissociative disorders - p. iii 430. Enuresis - p. iii 431. Catathrenia: sleep related groaning - p. iii 432. Exploding head syndrome - p. iii 433. Sleep related eating disorder - p. iii 434. Sexsomnia - p. iii 435. Associations and Consequences of Parasomnias - p. iii 436. Mood and behavior - p. iii 437. Health-related quality of life - p. iii 438. Diagnosis of Parasomnias - p. iii 439. History and physical examination, screening and case findings - p. iii 440. Value of polysomnography and other diagnostic tools to diagnose and treat parasomnias - p. iii 441. Diagnostic algorithms for parasomnias - p. iii 442. Treatment of Parasomnias - p. iii 443. Treatment of parsomnias - p. iii 444. Special considerations for the treatment of parasomnia - p. iii 445. Special Conditions, Disorders, and Clinical Issues of Parasomnias - p. iii 446. Parasomnias of childhood - p. iii 447. Effect of medications and substances on parasomnias - p. iii 448. Impact of medical and neurological disorders on parasomnias - p. iii 449. Parasomnia: impact of psychiatric disorders - p. iii 450. Legal implications of parasomnias - p. iii 451. Sleep and Other Conditions or Disorders - p. iii 452. Neurologic Disorders - p. iii 453. Neurological Conditions and Sleep - p. iii 454. Neuroinflammation, sleep, and autoimmune disease - p. iii 455. Headache and sleep - p. iii 456. Epilepsy and sleep - p. iii 457. Sleep disorders and stroke - p. iii 458. Parkinson disease and sleep - p. iii 459. CNS disease from toxins, alcohol and cannabis: effects on sleep - p. iii 460. Demyelinating diseases and sleep–update - p. iii 461. Neurodegenerative diseases and sleep - p. iii 462. Sleep and dementia - p. iii 463. Psychiatric Disorders - p. iii 464. Overview of the impact of psychiatric disorders on sleep - p. iii 465. Mood disorders and sleep - p. iii 466. Anxiety disorders and sleep - p. iii 467. Sleep disturbances in traumatic exposure and post-traumatic stress disorder - p. iii 468. Schizophrenia, other neuropsychiatric disorders and sleep - p. iii 469. Eating disorders and sleep - p. iii 470. Substance-related disorders and sleep - p. iii 471. Other Medical Conditions or Disorders - p. iii 472. Morbidity and mortality associated with sleep length - p. iii 473. Pain and sleep - p. iii 474. Fibromyalgia and sleep - p. iii 475. Visual impairment and circadian rhythm sleep disorders - p. iii 476. Cancer and sleep: is cancer a circadian rhythm disorder? - p. iii 477. Systemic and pulmonary hypertension and sleep - p. iii 478. Alterations in gastrointestinal functioning during sleep: clinical applications - p. iii 479. Renal disorders and sleep - p. iii 480. Nocturia - p. iii 481. Chronic fatigue syndrome and sleep - p. iii 482. Obsessive-compulsive disorders and sleep - p. iii 483. Cannabinoids and sleep - p. iii 484. Sleep in Special Populations - p. iii 485. Sleep Across the Lifespan - p. iii 486. Key differences in pediatric versus adult sleep - p. iii 487. Electrophysiological changes in sleep during childhood - p. iii 488. Neonates and infants - p. iii 489. Infant sleep: control of breathing and common sleep problems - p. iii 490. Children - p. iii 491. Sleep in adolescents - p. iii 492. Sleep in college students and young adults - p. iii 493. The impact of light and temperature on sleep in children and adolescents - p. iii 494. Sleep disorders in middle age - p. iii 495. Sleep in older adults - p. iii 496. Sleep in Children with Chronic Medical and Mental Health Issues - p. iii 497. Sleep in infants and children with medical disorders - p. iii 498. Sleep in children with genetic disorders - p. iii 499. Sleep disturbance in children with intellectual and neurodevelopmental disabilities - p. iii 500. Sleep in children with neurological disorders - p. iii 501. Sleep in children with attention-deficit/hyperactivity disorder - p. iii 502. Sleep disturbances in children and adolescents with mood disorders - p. iii 503. Sleep in children with anxiety disorders - p. iii 504. Sleep in children with autism spectrum disorders - p. iii 505. Sleep in children exposed to adverse or traumatic events - p. iii 506. Sleep in infants and children with chronic respiratory disorders - p. iii 507. Sleep in children with cancer and other chronic diseases - p. iii 508. Sleep in chronic pain and other pediatric conditions - p. iii 509. Sleep in Women - p. iii 510. Social and environmental factors that influence sleep in women - p. iii 511. Sleep in pregnancy and the postpartum - p. iii 512. The influence of maternal sleep disorders on fetal and neonatal outcome - p. iii 513. Sleep during transition to and after menopause (or sleep and menopause) - p. iii 514. Sleep Disparities: Ethnicity and Socioeconomic Factors - p. iii 515. A culturally responsive approach to understanding sleep health, race, and ethnicity - p. iii 516. A methodological approach to understanding ethnic inequities in sleep health - p. iii 517. Social and economic impact - p. iii 518. Sleep in Individuals with Special Occupational Demands or Life Circumstances - p. iii 519. Sleep in the caregiver - p. iii 520. The role of sleep in the military - p. iii 521. Sleep issues in aviation and space - p. iii 522. Sleep disturbances in nursing homes - p. iii 523. Sleep issues in people experiencing homelessness - p. iii 524. Sleep Health Promotion and Accommodations - p. iii 525. Sleep health promotion—what is it and how does it happen? - p. iii 526. Reasonable accommodations and modifications at school or work for individuals with residual sleepiness despite treatment of underlying sleep disorders - p. iii 527. Other Special Topics - p. iii 528. Sleep and anesthesia - p. iii 529. Sleep at high altitudes - p. iii 530. Chronic Mountain Sickness and Sleep - p. iii 531. Volume 6 - p. iii 532. Sleep/Circadian Rhythms and Technology - p. iii 533. Consumer and Research Wearable Devices - p. iii 534. Overview: wearable devices for monitoring sleep and circadian physiology - p. iii 535. Performance of consumer wearable sleep technology - p. iii 536. Measuring sleep in the bedroom environment - p. iii 537. Monitoring free-living circadian physiology - p. iii 538. The use of wearables in the sleep clinic and at home - p. iii 539. Artificial Intelligence and Machine Learning Algorithms - p. iii 540. How will artificial intelligence advance sleep medicine? - p. iii 541. Machine learning approaches in sleep and circadian research - p. iii 542. A review of automated sleep stage scoring - p. iii 543. Moving beyond sleep stage scoring epoch-by-epoch (other PSG/EEG characteristics and parameters) - p. iii 544. Internet and Cloud-Based Services - p. iii 545. Sleep, sleep disorders, and the Internet - p. iii 546. A device-agnostic cloud-based platform enabling tiered service provisioning for sleep disorders diagnosis and management - p. iii 547. New Diagnostic and Treatment Technologies - p. iii 548. Monitoring adherence to sleep and circadian disorders treatments - p. iii 549. Sleep telemedicine: present and future - p. iii 550. Emerging sleep “enhancement” technologies - p. iii 551. Continuous glucose monitoring in sleep and circadian research - p. iii 552. The Future of Sleep and Circadian Rhythm Medicine and Science - p. iii 553. Using technology and exposomics to understand and address sleep health disparities - p. iii 554. Use of technology for real-world sleep and circadian research - p. iii 555. Emerging technologies and their potential role in sleep medicine - p. iii 556. Index - p. iii 557. Authors - p. iii